128 related articles for article (PubMed ID: 14973067)
1. Small interfering double-stranded RNAs as therapeutic molecules to restore chemosensitivity to thymidylate synthase inhibitor compounds.
Schmitz JC; Chen TM; Chu E
Cancer Res; 2004 Feb; 64(4):1431-5. PubMed ID: 14973067
[TBL] [Abstract][Full Text] [Related]
2. Effect of 2'-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells.
Schmitz JC; Yu D; Agrawal S; Chu E
Nucleic Acids Res; 2001 Jan; 29(2):415-22. PubMed ID: 11139611
[TBL] [Abstract][Full Text] [Related]
3. A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and other solid tumours.
Jackman AL; Melin CJ; Kimbell R; Brunton L; Aherne GW; Theti DS; Walton M
Biochim Biophys Acta; 2002 Jul; 1587(2-3):215-23. PubMed ID: 12084463
[TBL] [Abstract][Full Text] [Related]
4. Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
Pandyra AA; Berg R; Vincent M; Koropatnick J
J Pharmacol Exp Ther; 2007 Jul; 322(1):123-32. PubMed ID: 17452420
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to thymidylate synthase as a target for cancer chemotherapy.
Li Q; Boyer C; Lee JY; Shepard HM
Mol Pharmacol; 2001 Mar; 59(3):446-52. PubMed ID: 11179438
[TBL] [Abstract][Full Text] [Related]
6. Development of modified siRNA molecules incorporating 5-fluoro-2'-deoxyuridine residues to enhance cytotoxicity.
Wu SY; Chen TM; Gmeiner WH; Chu E; Schmitz JC
Nucleic Acids Res; 2013 Apr; 41(8):4650-9. PubMed ID: 23449220
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stability.
Kitchens ME; Forsthoefel AM; Barbour KW; Spencer HT; Berger FG
Mol Pharmacol; 1999 Nov; 56(5):1063-70. PubMed ID: 10531414
[TBL] [Abstract][Full Text] [Related]
8. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed.
Peters GJ; van Triest B; Backus HH; Kuiper CM; van der Wilt CL; Pinedo HM
Eur J Cancer; 2000 May; 36(7):916-24. PubMed ID: 10785598
[TBL] [Abstract][Full Text] [Related]
9. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
[TBL] [Abstract][Full Text] [Related]
10. Effect of small interfering RNA 3'-end overhangs on chemosensitivity to thymidylate synthase inhibitors.
Schmitz JC; Chu E
Silence; 2011 Jan; 2(1):1. PubMed ID: 21247442
[TBL] [Abstract][Full Text] [Related]
11. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of a synergistic interaction between a thymidylate synthase inhibitor, ZD1694, and a novel lipophilic topoisomerase I inhibitor karenitecin, BNP1100: mechanisms and clinical implications.
Matsui S; Endo W; Wrzosek C; Haridas K; Seetharamulu P; Hausheer FH; Rustum YM
Eur J Cancer; 1999 Jun; 35(6):984-93. PubMed ID: 10533483
[TBL] [Abstract][Full Text] [Related]
13. Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene.
Yang Z; Cloud A; Hughes D; Johnson LF
Cancer Gene Ther; 2006 Jan; 13(1):107-14. PubMed ID: 16052228
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
Koehler SE; Ladner RD
Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
[TBL] [Abstract][Full Text] [Related]
15. Combining small interfering RNAs targeting thymidylate synthase and thymidine kinase 1 or 2 sensitizes human tumor cells to 5-fluorodeoxyuridine and pemetrexed.
Di Cresce C; Figueredo R; Ferguson PJ; Vincent MD; Koropatnick J
J Pharmacol Exp Ther; 2011 Sep; 338(3):952-63. PubMed ID: 21673071
[TBL] [Abstract][Full Text] [Related]
16. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
[TBL] [Abstract][Full Text] [Related]
17. Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression.
Sigmond J; Backus HH; Wouters D; Temmink OH; Jansen G; Peters GJ
Biochem Pharmacol; 2003 Aug; 66(3):431-8. PubMed ID: 12907242
[TBL] [Abstract][Full Text] [Related]
18. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
[TBL] [Abstract][Full Text] [Related]
19. Repression of human thymidylate synthase mRNA translation by antisense 2'-O-methyl oligoribonucleotides.
Schmitz JC; Agrawal S; Chu E
Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):371-8. PubMed ID: 9826264
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.
Copur S; Aiba K; Drake JC; Allegra CJ; Chu E
Biochem Pharmacol; 1995 May; 49(10):1419-26. PubMed ID: 7763285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
